In summary, the accumulating evidence suggests that IL-33 is pivotal in driving the Th2 immune response in RSV infections and serves as a potential biomarker for assessing disease severity and prognosis in infants suffering from bronchiolitis. This evidence concerns the gene IL33 and bronchiolitis.